Octave Specialty Group (NYSE:OSG – Get Free Report) is one of 311 publicly-traded companies in the “Insurance” industry, but how does it contrast to its rivals? We will compare Octave Specialty Group to similar companies based on the strength of its dividends, earnings, risk, profitability, valuation, institutional ownership and analyst recommendations.
Analyst Recommendations
This is a breakdown of current recommendations for Octave Specialty Group and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Octave Specialty Group | 1 | 2 | 2 | 0 | 2.20 |
| Octave Specialty Group Competitors | 3341 | 15702 | 16546 | 743 | 2.40 |
Octave Specialty Group presently has a consensus target price of $11.50, indicating a potential upside of 125.27%. As a group, “Insurance” companies have a potential upside of 4.78%. Given Octave Specialty Group’s higher possible upside, equities analysts clearly believe Octave Specialty Group is more favorable than its rivals.
Insider & Institutional Ownership
80.9% of Octave Specialty Group shares are held by institutional investors. Comparatively, 55.8% of shares of all “Insurance” companies are held by institutional investors. 7.2% of Octave Specialty Group shares are held by company insiders. Comparatively, 13.5% of shares of all “Insurance” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Octave Specialty Group and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Octave Specialty Group | -19.17% | 1.50% | 0.55% |
| Octave Specialty Group Competitors | 8.69% | -9.86% | 4.10% |
Valuation & Earnings
This table compares Octave Specialty Group and its rivals gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Octave Specialty Group | $251.22 million | -$261.69 million | -1.40 |
| Octave Specialty Group Competitors | $15.41 billion | $1.70 billion | 33.57 |
Octave Specialty Group’s rivals have higher revenue and earnings than Octave Specialty Group. Octave Specialty Group is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Octave Specialty Group has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, Octave Specialty Group’s rivals have a beta of -1.59, meaning that their average share price is 259% less volatile than the S&P 500.
Summary
Octave Specialty Group rivals beat Octave Specialty Group on 9 of the 13 factors compared.
Octave Specialty Group Company Profile
Octave Specialty Group Inc. is a specialty insurance company that provides underwriting solutions for complex, specialized and difficult-to-place risks. The company operates through specialty insurance platforms designed to serve customers and distribution partners seeking coverage outside standard commercial insurance markets. Its business activities include the development, underwriting and management of specialty insurance products across selected lines of business. Octave’s offerings are intended for niche risks that may require specialized expertise, tailored policy structures and disciplined risk selection.
Receive News & Ratings for Octave Specialty Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Octave Specialty Group and related companies with MarketBeat.com's FREE daily email newsletter.
